These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26086585)

  • 21. GPC Biotech receives Orphan Medicinal Product Designation.
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):246. PubMed ID: 12113046
    [No Abstract]   [Full Text] [Related]  

  • 22. Proving the principle: dendritic cell-based vaccines in urogenital cancers.
    Draube A; Klein-González N; von Bergwelt-Baildon M
    Expert Rev Vaccines; 2011 Oct; 10(10):1355-7. PubMed ID: 21988297
    [No Abstract]   [Full Text] [Related]  

  • 23. Dendritic-cell-based therapeutic vaccination against cancer.
    Nestle FO; Farkas A; Conrad C
    Curr Opin Immunol; 2005 Apr; 17(2):163-9. PubMed ID: 15766676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.
    Schreurs MW; Eggert AA; Punt CJ; Figdor CG; Adema GJ
    Crit Rev Oncog; 2000; 11(1):1-17. PubMed ID: 10795625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pilot trial of vaccines based on autologous dendritic cells loaded in vitro with tumor antigens in the treatment of cancer of the urinary bladder].
    Shoua AB; Sergienco NF; Sitnikov NV; Chkadua GZ
    Urologiia; 2008; (5):54-7. PubMed ID: 19069498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploiting dendritic cells in the development of cancer vaccines.
    Bracci L; Capone I; Moschella F; Proietti E; Belardelli F
    Expert Rev Vaccines; 2013 Oct; 12(10):1195-210. PubMed ID: 24090117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technology evaluation: DCVax, Northwest Biotherapeutics.
    Knutson KL
    Curr Opin Mol Ther; 2002 Aug; 4(4):403-7. PubMed ID: 12222879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vaccine therapy of prostate cancer].
    Doehn C; Böhmer T; Sommerauer M; Kausch I; Jocham D
    Aktuelle Urol; 2005 Sep; 36(5):407-16. PubMed ID: 16163603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cell therapy in advanced gastric cancer: a promising new hope?
    Tewari M; Sahai S; Mishra RR; Shukla SK; Shukla HS
    Surg Oncol; 2012 Sep; 21(3):164-71. PubMed ID: 22521560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cells: a journey from laboratory to clinic.
    Cerundolo V; Hermans IF; Salio M
    Nat Immunol; 2004 Jan; 5(1):7-10. PubMed ID: 14699398
    [No Abstract]   [Full Text] [Related]  

  • 31. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ vaccination combined with radiotherapy promising for low-grade lymphoma.
    Hum Vaccin Immunother; 2014; 10(12):3429. PubMed ID: 26052588
    [No Abstract]   [Full Text] [Related]  

  • 33. Dendritic cell vaccines to combat glioblastoma.
    Wheeler CJ
    Expert Rev Neurother; 2010 Apr; 10(4):483-6. PubMed ID: 20367199
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of computing technology on pharmaceutical and biotech research.
    Owen J
    IDrugs; 2005 Oct; 8(10):834-7. PubMed ID: 16254804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excitement tempered by long road ahead for dendritic cell vaccines.
    Vanchieri C
    J Natl Cancer Inst; 2004 Sep; 96(18):1350-1. PubMed ID: 15367563
    [No Abstract]   [Full Text] [Related]  

  • 36. Generation of dendritic cell-based vaccines for cancer therapy.
    Reinhard G; Märten A; Kiske SM; Feil F; Bieber T; Schmidt-Wolf IG
    Br J Cancer; 2002 May; 86(10):1529-33. PubMed ID: 12085199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter from the editor.
    Ellis RW; Riedmann EM
    Hum Vaccin Immunother; 2012 Mar; 8(3):281. PubMed ID: 22418878
    [No Abstract]   [Full Text] [Related]  

  • 38. Dendritic cell immunotherapy for glioblastoma.
    Polyzoidis S; Ashkan K
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):761-3. PubMed ID: 24850137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DCs in lymphoma--biology and therapeutic aspects.
    Schultze JL; Fiore F; von Bergwelt-Baildon M
    Cytotherapy; 2004; 6(2):138-47. PubMed ID: 15203990
    [No Abstract]   [Full Text] [Related]  

  • 40. Next generation personalized animals as an enabling technology in personalized vaccinology.
    Poland GA; Mirochnitchenko O
    Vaccine; 2013 Jan; 31(5):725-7. PubMed ID: 23337595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.